The AMPA receptor antagonist perampanel suppresses epileptic activity in human focal cortical dysplasia.
The AMPA receptor antagonist perampanel suppresses epileptic activity in human focal cortical dysplasia.
复制标题
DOI:
10.1002/epi4.12549
复制
发表时间:
2022-09
期刊:
影响因子:
3
通讯作者:
Cunningham, Mark O.
中科院分区:
文献类型:
--
作者:
Brito da Silva, Anderson;Pennifold, Jane;Henley, Ben;Chatterjee, Koustav;Bateman, David;Whittaker, Roger W.;Joshi, Abhijit;Kumar, Hrishikesh;Nicholson, Claire;Baker, Mark R.;Greenhill, Stuart D.;Walsh, Richard;Seri, Stefano;Jones, Roland S. G.;Woodhall, Gavin L.;Cunningham, Mark O.
Focal cortical dysplasia (FCD) is one of the most common malformations causing refractory epilepsy. Dysregulation of glutamatergic systems plays a critical role in the hyperexcitability of dysplastic neurons in FCD lesions. The pharmacoresistant nature of epilepsy associated with FCD may be due to a lack of well‐tolerated and precise antiepileptic drugs that can target glutamate receptors. Here, for the first time in human FCD brain slices, we show that the established, noncompetitive α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA) receptor antagonist, perampanel has potent antiepileptic action. Moreover, we demonstrate that this effect is due to a reduction in burst firing behavior in human FCD microcircuits. These data support a potential role for the treatment of refractory epilepsy associated with FCD in human patients.
登录
查看更多内容
DOI:
10.1073/pnas.0912652107
发表时间:
2010-01-05
影响因子:
11.1
作者:
Roopun, Anita K.;Simonotto, Jennifer D.;Cunningham, Mark O.
通讯作者:
Cunningham, Mark O.
影响因子:
2.5
作者:
Barygin, Oleg I.
通讯作者:
Barygin, Oleg I.
影响因子:
12.7
作者:
Finardi, Adele;Colciaghi, Francesca;Battaglia, Giorgio Stefano
通讯作者:
Battaglia, Giorgio Stefano
DOI:
10.1111/ane.12099
发表时间:
2013
期刊:
Acta neurologica Scandinavica. Supplementum
影响因子:
--
作者:
Rogawski MA
通讯作者:
Rogawski MA
影响因子:
9.9
作者:
Crino, PB;Duhaime, AC;White, R
通讯作者:
White, R